GlassScriptPhysician profile
Charles J Mentel
NPI 1154317014
$2,059.09
in general payments reported to CMS, 2019-2025
34 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $133 · 2022: $620 · 2023: $450 · 2024: $269 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $295.22 | 2020-2023 | |
| Astellas Pharma US INC | $269.09 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $196.95 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $185.47 | 2023-2024 | Myfembree, Gemtesa |
| Amgen INC. | $169.04 | 2019-2024 | Prolia, Evenity |
| Myovant Sciences INC. | $126.12 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.86 | 2020-2025 | |
| Hologic Sales and Service, LLC | $50.28 | 2020-2023 | Aptima |
| Coopersurgical, INC. | $46.17 | 2019-2020 | |
| Minerva Surgical, INC | $44.86 | 2019-2023 | |
| Amag Pharmaceuticals, INC. | $40.77 | 2019-2020 | |
| Sage Therapeutics, LLC | $37.13 | 2019-2025 | Zurzuvae |
| Conmed Corporation | $36.19 | 2025 | Visiclear, Vcare, Airseal |
| Mayne Pharma Commercial LLC | $36.17 | 2022-2023 | |
| Evofem Biosciences, INC. | $34.66 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $31.65 | 2023 | Intrarosa |
| Convatec INC. | $28.82 | 2024 | |
| Becton, Dickinson and Company | $28.25 | 2022 | |
| Mylan Pharmaceuticals INC. | $26.79 | 2019-2022 | |
| Allergan, INC. | $26.05 | 2019-2020 | |
| Kci USA, INC. | $24.20 | 2019 | |
| Organon LLC | $23.94 | 2023 | Nexplanon |
| Exeltis, USA INC. | $23.42 | 2022 | |
| Axonics, INC. | $20.86 | 2023 | Axonics |
| Solventum Corporation | $19.64 | 2025 | Prevena |
| Supernus Pharmaceuticals, INC. | $17.99 | 2025 | Qelbree |
| Merck Sharp & Dohme LLC | $17.77 | 2024 | Gardasil 9, Gardasil |
| Meditrina | $17.14 | 2025 | |
| Intuitive Surgical, INC. | $17.11 | 2019 | |
| Shield Therapeutics INC | $15.53 | 2023 | Accrufer |
| Scynexis, INC. | $15.08 | 2022 | |
| Therapeuticsmd, INC. | $14.52 | 2022 | |
| Roche Diagnostics Corporation | $14.50 | 2019 | |
| Duchesnay USA Incorporated | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Mentel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.